Patents for A61P 33 - Antiparasitic agents (21,787)
08/2005
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050169971 Pellet or tablet attractive to livestock masking a drug such as benazepril; animal feed substrate, intimately mixed with coated particles of a carrier material and an active ingredient casing that is coated by a masking protective layer
08/04/2005US20050169928 Antibodies which bind to proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes
08/03/2005EP1559321A1 Mixed compositions for controlling parasitic insects
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1196439B1 Compounds exhibiting an antibiotic activity
08/03/2005CN1650020A Means and methods for the production of adenovirus vectors
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649890A Anti-protozoal vaccine
08/03/2005CN1649874A Antiparasitic artemisinin derivatives (endoperoxides)
08/03/2005CN1649603A Aqueous compositions containing metronidazole
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649579A N-acylaminoacetonitrile derivatives and their use for controlling parasites
08/03/2005CN1649508A Use of fermented wheat-germ in feeding and veterinary practice
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924266 NTP-peptides and method for removal of tumors
08/02/2005US6924135 DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
08/02/2005US6924092 Testing prospective herbicides and parasiticides by incubating a substance with a monogalactodiacyl synthase or plastidal membrane products to select enzyme inhibitors; apicomplex parasites; antimalarial agents; coccidiosis;toxoplasmosis
08/02/2005US6923988 Solid carrier includes a hydrophililc surfactant and a drug
07/2005
07/28/2005WO2005068429A1 Derivatives of pyridine and quinoline
07/28/2005WO2005067951A1 Botanical extract composition
07/28/2005US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles
07/28/2005US20050165077 Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
07/28/2005US20050165068 Compounds, in particularly of urea derivatives or esters of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
07/28/2005US20050165052 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide
07/28/2005US20050163862 Suppressing cytokine secretion with such as sodium selenite; by the reduction in extra- and intracellular oxidative stress
07/28/2005CA2553953A1 Therapeutic use of quinonoid derivatives of cannabinoids
07/27/2005EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
07/27/2005EP1556007A2 Substituted tetracycline compounds for the treatment of malaria
07/27/2005EP1276376B1 Active substance combinations with insecticidal and acaricidal properties
07/27/2005EP0935462B1 Photopheresis treatment of leukocytes
07/27/2005CN1646152A Mannose binding lectin and uses thereof
07/27/2005CN1646131A Novel compounds
07/27/2005CN1646104A Dry granulated formulations of azithromycin
07/27/2005CN1644214A YG and YGG used as maintenance and improvement of immunoreaction
07/27/2005CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them
07/26/2005US6921826 Thioether substituted imidazoquinolines
07/26/2005US6921763 Protein kinase inhibitors
07/26/2005US6921762 Substituted indolizine-like compounds and methods of use
07/21/2005WO2005065063A2 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies
07/21/2005US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy
07/21/2005US20050158278 Means and methods for the production of adenovirus vectors
07/21/2005US20050158277 Method to genetate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production
07/21/2005US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying
07/20/2005EP1553970A1 Treatment of allergic conditions by use of il 21
07/20/2005EP1286673B8 Ligands of integrin receptors
07/20/2005EP1261328B1 Il-8 receptor antagonists
07/20/2005EP0929677B1 Recombinant method for preparing a complete malaria antigen gp190/msp1
07/20/2005CN1643382A A cytocapacity test
07/20/2005CN1642966A Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
07/20/2005CN1640493A Leptospira vaccine
07/20/2005CN1640492A 一种钩端螺旋体外膜蛋白疫苗 One kind of Leptospira outer membrane protein vaccine
07/20/2005CN1211126C Vascular endothelial growth factor 2
07/19/2005US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
07/19/2005US6919090 Active substance combinations with insecticidal and acaricidal properties
07/14/2005WO2005062748A2 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
07/14/2005US20050154215 Extraction from Zanthoxylum naranjillo leaves; nuclear magnetic resonance; for treatment of Chaga's disease
07/14/2005US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis
07/14/2005US20050154003 Containing a 1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinoline ring, e.g., {10-[(E)-(ter-butoxyimino)methyl]-3-ethyl-1,13-dioxo-11,13-dihydro-1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinolin-3-yl}acetic acid; topoisomerase I inhibitors used to treat cancer
07/14/2005US20050153997 Fredericamycin derivatives
07/14/2005US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects
07/14/2005CA2550344A1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof
07/13/2005EP1552848A1 Compositions against chicken coccidiosis
07/13/2005EP1552844A1 Botanical extract composition
07/13/2005EP1551445A2 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy
07/13/2005EP1551390A1 Levamisole, avermectins or similar in pyrrolidone solvent
07/13/2005EP1551375A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant
07/13/2005EP1551330A1 Improvements in delivery technology
07/13/2005EP1551228A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
07/13/2005EP1551221A2 Nucleic acid compositions for stimulating immune responses
07/13/2005EP1161415B1 N-cyanomethylamides as protease inhibitors
07/13/2005EP0938308B1 Antiparasitic agents
07/13/2005CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
07/13/2005CN1638770A Composition and potentiating method
07/13/2005CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
07/13/2005CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
07/13/2005CN1637011A Avermectin derivatives
07/13/2005CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k
07/13/2005CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds
07/13/2005CN1210064C Compositions for the treatment of coccidiosis
07/13/2005CN1210040C Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease
07/12/2005US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists
07/12/2005CA2351429C 13-membered azalides and their use as antibiotic agents
07/12/2005CA2341739C Quinolin-2-one derivatives useful as anticancer agents
07/07/2005US20050148628 Treatment of malaria with mixtures of artesunate and mefloquine for three days and blister packs of medicine
07/07/2005US20050148619 Sulfonamido ether substituted imidazoquinolines
07/07/2005US20050148569 Targeted oxidative therapeutic formulation
07/07/2005US20050148568 Treating sarcocystis protozoa infected horses; peroxidic species from oxidation of such as geraniol, penetrating solvent;, metal chelated dye and aromatic redox compound; activating with ionizing radiation
07/07/2005US20050148566 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
07/07/2005US20050148537 Immunostimulatory nucleic acid molecules
07/07/2005US20050148520 Avermectin derivatives
07/07/2005US20050148503 Comprises erythropoietin as active ingredient; for treatment of anemia, trypanosomiasis, or malaria
07/07/2005US20050148014 Regulation of human P2Y1-like G protein-coupled receptor
07/07/2005US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation
07/06/2005EP1549761A1 Methods and compositions for the modification of nucleic acids
07/06/2005EP1549291A1 Injection formulation
07/06/2005EP1490315A4 Controlling chemical reactions by spectral chemistry and spectral conditioning
07/06/2005CN1636063A Genetic vaccine against human immunodeficiency virus
07/06/2005CN1635979A IL-8 receptor antagonists
07/06/2005CN1635912A Targeted delivery of drugs for the treatment of parasitic infections